ecancer

A basket full of targeted therapies

Prof Eric Winer - Dana-Farber Cancer Institute, Boston, USA

15 Jul 2009

Proton beam radiotherapy for breast cancer

Prof Alphonse Taghian - Massachusetts General Hospital, Boston, USA

15 Jul 2009

Endocrine treatment for prevention of breast cancer

Dr Andrea Decensi - Galliera Hospital, Genoa, Italy

15 Jul 2009

Breast cancer prevention targets

Dr Karen Johnson - National Cancer Institute, USA

15 Jul 2009

Genetic determinants for breast cancer spread

Dr Kent Hunter - National Cancer Institute, Bethesda, USA

8 Jul 2009

MicroRNAs regulating cancer stem cell self renewal

Dr Michael Clarke - Stanford School of Medicine, USA

8 Jul 2009

Study of the extra cellular matrix around cancer cells and 3D assays

Dr Mina Bissell - Lawrence Berkeley National Laboratory, USA

8 Jul 2009

Targeting death receptors in chemo-resistant cancer cells

Prof Patrick Johnston - Queen's University Belfast, UK

3 Jul 2009

Olaparib induces tumour response as single agent in BRCA-deficient breast cancer

Dr Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London, UK

3 Jul 2009

PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast cancer

Dr Joyce O'Shaughnessy - Baylor-Charles A. Sammons Cancer Center, US

3 Jul 2009

PARP inhibitors show promise for hard-to-treat breast cancers

Dr. Andrew Tutt - Breakthrough Breast Cancer Research Unit, Kings College London, UK

25 Jun 2009

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

Dr. Jacek Gronwald, International Hereditary Cancer Centre, Poland

25 Jun 2009

More from ecancer